Royal Philips reports before the bell on a critical quarter for its FDA-constrained sleep and respiratory care business, where recovery momentum could reset investor expectations after the consent decree.
Philips :
PHG
PHG
Stock Data
$25.53
$0.51 (2.03%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DEVICES
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.
Latest Activity
Philips blew past expectations with a 51% EPS beat and 15% revenue beat, but the standout numbers lean heavily on a $211 million US tariff refund that inflated operating income by 4.2 percentage points. Guidance raised across adjusted margins and free cash flow, though lingering Respironics legal clouds with the DOJ and state attorneys general continue to shadow investor appetite.
All Philips Articles
60 Articles